Pharma

In the evolving landscape of chronic disease and cellular aging, we have come to understand that skin health is far more than a cosmetic concern; it is a vital indicator of systemic vitality and the body's regenerative capacity. At DeanSilverMD.com, we view the skin as the body's largest organ and its primary barrier against environmental stressors that drive chronic … [Read more...] about Seranova

By DeanSilverMD.com Editorial Team When you're researching weight loss medications online, legitimate concerns about scams and questionable providers surface quickly. Telehealth platforms offering compounded tirzepatide and semaglutide occupy a gray zone that raises reasonable questions. Is MEDVI legitimate? Is MEDVI a scam? Are you actually getting pharmaceutical-grade … [Read more...] about Is MEDVI Legit? Investigating This Telehealth Tirzepatide Provider’s Credibility and Safety

The U.S. Food and Drug Administration (FDA) has issued important updates regarding GLP-1 receptor agonists, such as semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound®). These medications have gained widespread use for weight management, but concerns regarding their availability, safety, and the risks of compounded versions have led to increased regulatory … [Read more...] about FDA’s GLP-1 Clarification: A Step Toward Safer, More Reliable Weight Loss Treatments

In the ever-evolving landscape of weight management, GLP-1 receptor agonists such as semaglutide and tirzepatide have emerged as powerful tools for regulating appetite and blood sugar. These medications, originally developed for diabetes treatment, have gained widespread attention for their ability to aid in weight loss. However, with their growing popularity, the rise of … [Read more...] about Weight Loss and Unapproved GLP-1 Drugs: The Science Behind the FDA’s Concerns